Executive Summary
Cholangiocarcinoma is the type of bile duct cancer majorly forming in the bile ducts. Approximately 0.5–2 individuals per 100,000 each year are affected by Cholangiocarcinoma, mainly in the Western region. The individuals belo...
Executive Summary
Cholangiocarcinoma is the rare cancer type prevalent in the US region, with 2000-3000 new cases diagnosed every year. The prevalence ranges from 0.01%-0.46%. The breakout of chronic parasite infestation resulted in a higher majo...
Executive Summary
Bile duct cancer originates in the bile duct's cells. The digestive system includes the bile ducts, a yellow-green fluid that aids in the digestion of lipids. The bile duct cells alter their growth resulting in non-cancerous (be...
Executive Summary
There are several risk factors associated with cholangiocarcinoma. Primary sclerosing cholangitis (PSC), parasite liver infections, chronic liver illness, cognitive liver abnormalities, thorotrast are the common risk factors for...
Executive Summary
Bile duct cancer is difficult to treat. Therefore its prevention is considered an important aspect. Some of the primary preventive measures include maintaining a healthy weight, consumption of nutritious food, alcohol consumpti...
Executive Summary
The signs and symptoms help in the diagnosis of any particular disease. The symptoms entirely depend upon the location of tumor. The common symptoms of bile duct cancer include abnormalities in liver functioning, jaundice, abdom...
Executive Summary
Different tests are being conducted for the diagnosis of bile duct cancer. No specific blood tests are shown for the diagnosis of bile duct cancer. Carcinoembryonic antigen (CEA) and CA19-9 levels in the blood are conjugated wit...
Executive Summary
The staging system of bile duct cancer depends upon the size of the tumor, its metastasis and its time of occurrence. The TNM staging system is used as staging approach for bile duct carcinoma. The total five stages of bile duct...
Executive Summary
The different types of standard treatments for bile duct cancer are explained in detail. Standard treatments are used along with the integration of effective treatment planning. Clinical trials are used as an innovative treatmen...
Executive Summary
Clinical trials are considered a better method for treating bile duct cancer. The evaluation of new drugs, different combinations of treatments, new approaches to radiation therapy or surgery, and new therapies are integrated in...
Executive Summary
Several research studies have been conducted to seek more information on bile duct cancer, their related prevention method, their diagnostic approach at the initial phase, and the best treatments strategies. Bile duct tumour res...
Executive Summary
Managing the side effects in treating bile duct cancer is considered a fundamental approach. Vomiting and nausea are the common side effects experienced by patients undergoing treatment for bile duct tumour. Distraction, relax...
Executive Summary
Follow-up care for bile duct cancer refers to the after-treatment protocols conducted by the healthcare team to look after recurrence, manage the side effects, and monitor the patients’ overall health. If the patient has any s...
Executive Summary
Survivorship begins immediately after the diagnosis of cancer. The individuals under treatment and whose disease conditions are cured after the treatment are referred to as the cancer survivors. Survival is considered one of the...
It is critical to communicate with your health care team regularly to make informed decisions regarding your health care. So, ask questions about Bile Duct Cancer and clarify your doubts.
Questions to Ponder After a Bile Duct Cancer Diagnosis
...
Here are a few links to help you find more about Bile duct cancer:
https://www.mayoclinic.org/diseases-conditions/bileduct-cancer/symptoms-causes/syc-20356104https://www.cancer.org/cancer/bladder-cancer/about/what-is-bladder-cancer.htmlhttps://ww...